Ruilian Xu

1.7k citations
40 papers · 388 indexed · h-index 13
Topics
Advanced Proteomics Techniques and Applications (10 papers)Glycosylation and Glycoproteins Research (5 papers)Mass Spectrometry Techniques and Applications (5 papers)

In The Last Decade

Ruilian Xu

37 papers receiving 383 citations

Peers

Ruilian Xu
Comparison fields: 5 of 78
  • Molecular Biology 218
  • Oncology 113
  • Cancer Research 111
  • Spectroscopy 110
  • Pulmonary and Respiratory Medicine 48
Replace Lucía Trilla‐Fuertes with:
Lucía Trilla‐Fuertes Spain
Sylvie Michelland France
Marie‐Christine W. Gast Netherlands
Judith YMN Engwegen Netherlands
Zhefeng Xiao China
Jo Ballot Ireland
Chinmayi Prasanna Singapore
Qiang Qin China
Chris Benz United States
Danica Wiredja United States
Ruilian Xu relative to Lucía Trilla‐Fuertes Spain Lucía Trilla‐Fuertes's profile →
Citations per field
00.5×5.5×
Lucía Trilla‐Fuertes · 1×
Citations per year

Countries citing papers authored by Ruilian Xu

Since Specialization
Citations

This map shows the geographic impact of Ruilian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruilian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruilian Xu more than expected).

Fields of papers citing papers by Ruilian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruilian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruilian Xu. The network helps show where Ruilian Xu may publish in the future.

Co-authorship network of co-authors of Ruilian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruilian Xu. A scholar is included among the top collaborators of Ruilian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruilian Xu. Ruilian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2 1
3 5
4 1
5 1
6 6
7 9
8 0
9 2
10 1
11 2
12 0
13 24
14 31
15 1
16 11
17 32
18 28
19 22
20 8

About Ruilian Xu

Ruilian Xu is a scholar working on Cancer Research, Spectroscopy and Oncology, having authored 40 papers that have together received 388 indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (10 papers), Glycosylation and Glycoproteins Research (5 papers) and Mass Spectrometry Techniques and Applications (5 papers). The work is most often cited by research in Cancer Research (111 citations), Spectroscopy (110 citations) and Oncology (113 citations). Ruilian Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Ruijun Tian, Wan He, Weina Gao, Jun Tang, Jinghua Chen, Bizhu Chu, An He, Wendong Chen, Hua Cao and Senming Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026